BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
The National Council of Insurance Legislators is in the early planning stages of possibly creating a model law on workers compensation drug formularies, the organization’s spokesman confirmed on Friday.
Details on the proposed NCOIL Workers’ Compensation Drug Formulary Model Act are included in NCOIL’s spring meeting agenda, provided to Business Insurance. The meeting is set for March 14-17 in Nashville and is the first time the organization is set to discuss a model law for states that want to adopt drug formularies for injured workers, according to the spokesman.
The language for the model law is based on Indiana’s formulary bill, S.B. 369, enacted in 2018, and “is meant for initial discussion for development” of the model law, according to a draft notice. “This topic will be discussed throughout 2019,” it states.
Indiana’s formulary is based on the Official Disability Guidelines, or ODG, Workers’ Compensation Drug Formulary, published by Austin, Texas-based MCG Health LLC. The evidence-based drug list is the most common formulary used in states that have adopted workers compensation drug formularies.
As of 2019, 12 states have adopted legislature-backed formularies for workers compensation.
Pennsylvania Gov. Tom Wolf on Friday vetoed a bill that would have brought a drug formulary into the state’s workers compensation system.